真性脾动脉瘤腔内治疗现状
作者:
作者单位:

(中国医学科学院北京协和医院血管外科,北京 100730)

作者简介:

通讯作者:

中图分类号:

R543.1+6

基金项目:

国家自然科学基金重大项目(51890892);国家自然科学基金面上项目(81770481);北京市自然科学基金面上项目(7172171);中国医学科学院医学与健康科技创新工程经费资助(2017-I2M-1-008)


Satus quo of endovascular treatment of true splenic aneurysm
Author:
Affiliation:

(Department of Vascular Surgery, Peking Union Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    脾动脉瘤是最常见的内脏动脉瘤,常为孤立囊状,多与高龄、妊娠、门静脉血流增加等存在关联,其破裂风险较高。现阶段对于脾动脉瘤治疗方式的选择尚存在较多争议,急诊破裂情况下多选用传统开放手术,而择期手术情况下腔内治疗因创伤小、术后恢复较快备受青睐。无论是传统开放手术还是腔内介入治疗,均存在一定的优缺点,但因缺乏相应的循证医学证据,对脾动脉瘤尚未形成统一的治疗观点。因此,关于脾动脉瘤腔内治疗方式的选择、远期治疗效果以及围手术期抗凝抗血小板药物的应用尚需进一步研究。

    Abstract:

    Splenic aneurysms are the most common visceral aneurysms, which are usually isolated sacs. Most of them are associated with old age, pregnancy, and increased portal vein blood flow with a high risk of rupture. At present, the choice of the treatment of splenic aneurysms remains controversial. Traditional open surgery is mostly used for emergency ruptures, while endovascular treatment is favored for elective surgery because of the slight trauma and rapid postoperative recovery. Both procedures have their own advantages and disadvantages. Lack of evidence-based medicine results in controversy concerning the treatment of splenic aneurysms. Therefore, further study is needed for the choice of endovascular treatment, long-term therapeutic effect and the application of perioperative anti-coagulant and antiplatelet drugs.

    参考文献
    相似文献
    引证文献
引用本文

任金锐,张慧,崔立强,郑月宏.真性脾动脉瘤腔内治疗现状[J].中华老年多器官疾病杂志,2020,19(1):59~61

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2019-10-09
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-01-16
  • 出版日期: